We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Lumme is a digital therapeutics company developing a continuous health monitoring and intervention platform. Using our technology platform, we have clinically demonstrated significant patient behavior change during the treatment period. We have received $1.8M in government grants to use our technology platform to develop products that target the top 3 addictions grappling our nation today: smoking, alcohol, and diet. Our 1st product is a smoking cessation platform that has demonstrated the highest clinically reported quit rates of any commercially available product or service. This work is an outcome of research conducted at UMass Amherst, co-developed with the Yale Tobacco Treatment Clinic, and funded by the National Cancer Institute.